Summary of all studies containing PUBCHEM ID 24778634
| Project | Study | Study_title | Subject_type | Subject_species | Metabolite_name |
|---|---|---|---|---|---|
| PR000907 | ST002089 | Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. | Human | Homo sapiens | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* [Data] |
| PR001048 | ST002088 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema | Human | Homo sapiens | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* [Data] |
| PR001139 | ST001795 | Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib (part I) | Mammal | Mus musculus | PC 32:1 [Data] |
| PR001139 | ST001796 | Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib | Mammal | Mus musculus | PC 30:1 [Data] |
| PR001180 | ST001869 | WNK463 Inhibition on Right Ventricular metabolomics | Mammal | Rattus norvegicus | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* [Data] |
| PR001180 | ST001870 | Effects of GP130 Antagonism on Right Ventricular Metabolism in Monocrotaline Rats | Mammal | Rattus norvegicus | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* [Data] |
| PR001285 | ST002023 | A targeted metabolomics study for assessing rodent thyroid toxicity | Mammal | Rattus norvegicus | Glycerophospholipids__PC aa C34:4 [Data] |
| PR001400 | ST002196 | Metabolic signature of idiopathic inflammatory myopathy | Human | Homo sapiens | PC aa C34:4 [Data] |
| PR001451 | ST002269 | Targeted plasma metabolomics in pediatric NAFLD patients | Human | Homo sapiens | PC(34:4) [Data] |
| PR001488 | ST002322 | Metabolomics study comparing SCAP KO and WT B cells | Cultured cells | Mus musculus | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* [Data] |
| PR001613 | ST002498 | Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort | Human | Homo sapiens | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* [Data] |
| PR001715 | ST002754 | Metabolomics analysis of maternal obesity model | Mammal | Mus musculus | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* [Data] |
| PR001756 | ST002809 | Role of cilia in mitochondrial function | Mammal | Mus musculus;Canis lupus familiaris | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* [Data] |
| PR001764 | ST002822 | Effect of ERR Agonist in Mouse Heart Post Pressure Overload | Mammal | Mus musculus | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* [Data] |
| PR001771 | ST002829 | Nucleotide, phospholipid, and kynurenine metabolites are robustly associated with COVID-19 severity and time of plasma sample collection in a prospective cohort study | Human | Homo sapiens | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* [Data] |
| PR001809 | ST002909 | Plasma metabolomics reveals distinct biological and diagnostic signatures for melioidosis | Human | Homo sapiens | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* [Data] |
| PR001883 | ST003222 | A small molecule macrophage migration inhibitory factor agonist ameliorates age-related myocardial intolerance to ischemia-reperfusion insults via metabolic regulation - Part 1 | Mammal | Mus musculus | PC(14:0_20:4) [Data] |
| PR001890 | ST003038 | Untargeted lipidomics of WT and Cyp2c44(-/-) mice liver. | Mammal | Mus musculus | PE 37:4|PE 17:0_20:4 (754.53998@8.668) [Data] |
| PR001952 | ST003277 | LC-MS/MS spatial analysis of mouse GI | Mammal | Mus musculus | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* [Data] |
| PR002165 | ST003520 | Identification of Plasma Metabolomic Biomarkers of Juvenile Idiopathic Arthritis | Human | Homo sapiens | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* [Data] |
